Research output per year
Research output per year
Personal profile
Expertises
Cardiac research, arrhythmia, atrial fibrillation, clinical trials, biomarker research, interventional trials, physical exercise.
Main research areas
Cardiac research, arrhythmia, atrial fibrillation, clinical trials, biomarker research, interventional trials, physical exercise.
Current research
Invasive and non-invasive electrophysiology, atrial fibrillation, arrhythmia in heart failure, biomarkers and atrial fibrillation, temporal patterns in atrial fibrillation relapses, physical exercise and atrial fibrillation.
Potential conflicts of interest
Speakers / educational fees from Bayer A/S, Boehringer-Ingelheim A/S, BMS.
Research support from Boehringer-Ingelheim A/S.
External positions
University of Copenhagen
2005 → …
Fingerprint
Dive into the research topics where Ulrik Dixen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Association between interleukin-6, suPAR, and hsCRP with subclinical left ventricular dysfunction in type 1 diabetes: The Thousand & 1 study
Bahrami, H. S. Z., Jørgensen, P. G., Hove, J. D., Dixen, U., Rasmussen, L. J. H., Eugen-Olsen, J., Rossing, P. & Jensen, M. T., Apr 2025, In: Diabetes Research and Clinical Practice. 222, p. 112071 112071.Research output: Contribution to journal › Journal article › Research › peer-review
-
Screening of Diabetic and Heart Failure Patients for Silent Atrial Fibrillation
Silajdzija, E., Lund, I. M., Jensen, J. B., Sheikh, A. P., Hansen, J. L., Tourkaman, M., Heinesen, V., Kallemose, T., Lillqvist, J., Steinwender, C., Clodi, M., Hendrikx, T., Engdahl, J., Pürerfellner, H. & Dixen, U., Mar 2025, In: CJC open. 7, 3, p. 262-269 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic biomarker in acutely admitted patients with atrial fibrillation
Wisborg, F. D., El Caidi, N. O., Taraldsen, I. A., Tonning, S., Kandiah, A., El-Sheikh, M., Bahrami, H. S. Z., Andersen, O., Rasmussen, L. J. H., Hove, J., Dixen, U. & Grand, J., Apr 2025, In: Journal of Arrhythmia. 41, 2, p. e70077 e70077.Research output: Contribution to journal › Journal article › Research › peer-review
-
Automated oxygen administration versus manual control in acute cardiovascular care: a randomised controlled trial
Taraldsen, I. A., Grand, J., Lukoschewitz, J. D., Seven, E., Dixen, U., Petersen, M., Rytoft, L., Jakobsen, M. M., Hansen, E. F. & Hove, J. D., 13 Dec 2024, In: Heart (British Cardiac Society). 111, 1, p. 27-34 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Interleukin-6 and suPAR are associated with diastolic function in type 1 diabetes: The Thousand & 1 Study
Bahrami, H. S. Z., Jorgensen, P. G., Hove, J. D., Dixen, U., Rasmussen, L. J. H., Eugen-Olsen, J., Rossing, P. & Jensen, M. T., 28 Oct 2024, In: European Heart Journal. 45, 1, SI, ehae666.953.Research output: Contribution to journal › Conference abstract in journal › Research › peer-review